Published in PLoS One on May 30, 2012
IL-12 based gene therapy in veterinary medicine. J Transl Med (2012) 0.82
Clinical trials of immunogene therapy for spontaneous tumors in companion animals. ScientificWorldJournal (2014) 0.80
RGS16, a novel p53 and pRb cross-talk candidate inhibits migration and invasion of pancreatic cancer cells. Genes Cancer (2014) 0.76
The cancer growth suppressor gene mda-7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice. Proc Natl Acad Sci U S A (1998) 1.69
mda-7/IL-24, a novel cancer selective apoptosis inducing cytokine gene: from the laboratory into the clinic. Cancer Biol Ther (2003) 1.63
Mutations in the retinoblastoma-related gene RB2/p130 in lung tumors and suppression of tumor growth in vivo by retrovirus-mediated gene transfer. Cancer Res (2000) 1.45
Postvaccination sarcomas in cats. J Am Vet Med Assoc (1993) 1.42
mda-7/IL-24, novel anticancer cytokine: focus on bystander antitumor, radiosensitization and antiangiogenic properties and overview of the phase I clinical experience (Review). Int J Oncol (2007) 1.34
Eradication of therapy-resistant human prostate tumors using a cancer terminator virus. Cancer Res (2007) 1.31
MDA-7/IL-24: novel cancer growth suppressing and apoptosis inducing cytokine. Cytokine Growth Factor Rev (2003) 1.31
Cell cycle control and beyond: emerging roles for the retinoblastoma gene family. Oncogene (2006) 1.29
Emerging roles for Rab family GTPases in human cancer. Biochim Biophys Acta (2009) 1.22
Eradication of therapy-resistant human prostate tumors using an ultrasound-guided site-specific cancer terminator virus delivery approach. Mol Ther (2009) 1.14
A cancer terminator virus eradicates both primary and distant human melanomas. Cancer Gene Ther (2008) 1.05
p53 protein expression in conjunctival squamous cell carcinomas of domestic animals. Vet Ophthalmol (1999) 1.01
Rapid selection and proliferation of CD133+ cells from cancer cell lines: chemotherapeutic implications. PLoS One (2010) 0.98
Combined doxorubicin and cyclophosphamide chemotherapy for nonresectable feline fibrosarcoma. J Am Anim Hosp Assoc (2000) 0.95
Local immunotherapy of spontaneous feline fibrosarcomas using recombinant poxviruses expressing interleukin 2 (IL2). Gene Ther (2003) 0.91
mda-7 (IL-24): signaling and functional roles. Biotechniques (2002) 0.91
Intra-tumoral gene delivery of feIL-2, feIFN-gamma and feGM-CSF using magnetofection as a neoadjuvant treatment option for feline fibrosarcomas: a phase-I study. J Vet Med A Physiol Pathol Clin Med (2007) 0.89
Janus faces of ras: anti or pro-apoptotic? Apoptosis (1999) 0.88
Unique conditionally replication competent bipartite adenoviruses-cancer terminator viruses (CTV): efficacious reagents for cancer gene therapy. Cell Cycle (2006) 0.86
Gene therapy of spontaneous canine melanoma and feline fibrosarcoma by intratumoral administration of histoincompatible cells expressing human interleukin-2. Gene Ther (1996) 0.84
Feline fibrosarcomas at vaccination sites and non-vaccination sites. J Comp Pathol (1996) 0.84
Liposome-encapsulated doxorubicin (Doxil) and doxorubicin in the treatment of vaccine-associated sarcoma in cats. J Vet Intern Med (2002) 0.83
Electrochemotherapy-induced radiation recall in a cat. In Vivo (2009) 0.83
Immunohistochemical detection of tumor suppressor gene p53 protein in feline injection site-associated sarcomas. Vet Pathol (2001) 0.81
Amplification of the major satellite DNA family (FA-SAT) in a cat fibrosarcoma might be related to chromosomal instability. J Hered (2006) 0.80
Cell lines derived from feline fibrosarcoma display unstable chromosomal aneuploidy and additionally centrosome number aberrations. Vet Pathol (2011) 0.79
Cytogenetic alterations in four feline soft-tissue tumours. Vet Res Commun (1998) 0.78
Presence of p53 mutations in feline neoplasms. Res Vet Sci (2000) 0.78
Adjuvant immunotherapy of feline fibrosarcoma with recombinant feline interferon-omega. J Vet Intern Med (2008) 0.77
Etiology of feline vaccine-associated sarcomas: history and update. J Am Vet Med Assoc (1998) 0.77
Injection-site sarcomas in cats. J Am Vet Med Assoc (1998) 0.77
Tumor suppressor genes as cancer therapeutics. Drug News Perspect (2007) 0.77
Mutations in tumour suppressor gene p53 in two feline fibrosarcomas. Br Vet J (1996) 0.77
Vaccination and fibrosarcomas in cats. Vet Rec (1994) 0.77
Multicentric fibrosarcoma in a cat and a review of the literature. Can Vet J (1984) 0.76
Vaccine-associated fibrosarcoma in a cat. Can Vet J (2003) 0.76
Molecular cloning and chromosomal mapping of feline p53 tumor suppressor gene. J Vet Med Sci (1993) 0.76
The issue of injection site sarcomas. J Am Vet Med Assoc (1997) 0.76
Epigenetic information and estrogen receptor alpha expression in breast cancer. Oncologist (2006) 1.70
Use of autologous platelet-rich plasma (PRP) in periodontal defect treatment after extraction of impacted mandibular third molars. J Oral Maxillofac Surg (2005) 1.68
Differentiation of human adult cardiac stem cells exposed to extremely low-frequency electromagnetic fields. Cardiovasc Res (2009) 1.65
Transcriptional regulation of HIV-1 gene expression by p53. Cell Cycle (2010) 1.47
Molecular basis of angiogenesis and cancer. Oncogene (2003) 1.38
Ezh2 reduces the ability of HDAC1-dependent pRb2/p130 transcriptional repression of cyclin A. Oncogene (2004) 1.16
Eradication of therapy-resistant human prostate tumors using an ultrasound-guided site-specific cancer terminator virus delivery approach. Mol Ther (2009) 1.14
Ultrasound guided site specific gene delivery system using adenoviral vectors and commercial ultrasound contrast agents. J Cell Physiol (2006) 1.07
Immunohistochemical analysis of pRb2/p130, VEGF, EZH2, p53, p16(INK4A), p27(KIP1), p21(WAF1), Ki-67 expression patterns in gastric cancer. J Cell Physiol (2007) 1.02
Developing an effective gene therapy for prostate cancer: New technologies with potential to translate from the laboratory into the clinic. Discov Med (2011) 1.01
Chondrosarcoma of the jaw: a closer look at its management. J Oral Maxillofac Surg (2008) 0.98
Rapid selection and proliferation of CD133+ cells from cancer cell lines: chemotherapeutic implications. PLoS One (2010) 0.98
Effects of single and multi walled carbon nanotubes on macrophages: cyto and genotoxicity and electron microscopy. Mutat Res (2011) 0.98
Platelet-rich plasma and resorbable membrane for prevention of periodontal defects after deeply impacted lower third molar extraction. J Oral Maxillofac Surg (2009) 0.97
Gene-expression analysis identifies novel RBL2/p130 target genes in endemic Burkitt lymphoma cell lines and primary tumors. Blood (2007) 0.96
Expression of RB2/p130 tumor-suppressor gene in AIDS-related non-Hodgkin's lymphomas: implications for disease pathogenesis. Hum Pathol (2002) 0.91
Omega-3 eicosapentaenoic acid decreases CD133 colon cancer stem-like cell marker expression while increasing sensitivity to chemotherapy. PLoS One (2013) 0.90
Expression of cell cycle-regulated proteins pRB2/p130, p107, E2F4, p27, and pCNA in salivary gland tumors: prognostic and diagnostic implications. Clin Cancer Res (2005) 0.90
Cadmium induces p53-dependent apoptosis in human prostate epithelial cells. PLoS One (2012) 0.90
How does the human RUNX3 gene induce apoptosis in gastric cancer? Latest data, reflections and reactions. Cancer Biol Ther (2006) 0.89
TNF-alpha signal transduction in rat neonatal cardiac myocytes: definition of pathways generating from the TNF-alpha receptor. FASEB J (2002) 0.88
Immunohistochemical evaluation of pRb2/p130, VEGF, EZH2, p53, p16, p21waf-1, p27, and PCNA in Barrett's esophagus. J Cell Physiol (2006) 0.86
New palatal distraction device by both bone-borne and tooth-borne force application in a paramedian bone anchorage site: surgical and occlusal considerations on clinical cases. J Craniofac Surg (2014) 0.86
pRb2/p130 and VEGF expression in endometrial carcinoma in relation to angiogenesis and histopathologic tumor grade. Cancer Biol Ther (2006) 0.85
Isolation and characterization of some mycelia inhabiting Tuber ascomata. Mycol Res (2007) 0.84
Intraoral epimucosal fixation for reducible maxillary fractures of the jaws; surgical considerations in comparison to current techniques. J Craniofac Surg (2014) 0.83
pRb2/p130 promotes radiation-induced cell death in the glioblastoma cell line HJC12 by p73 upregulation and Bcl-2 downregulation. Oncogene (2002) 0.83
Adenoviral gene therapy in head and neck cancer. Drug News Perspect (2006) 0.83
Outcome of 50 consecutive sinus lift operations. Br J Oral Maxillofac Surg (2005) 0.82
Human immunodeficiency virus type 1 (HIV-1) derived vectors: safety considerations and controversy over therapeutic applications. Eur J Dermatol (2003) 0.82
Chin Wing Osteotomy for Bilateral Goldenhar Syndrome Treated by "Chin Wing Mentoplasty": Aesthetic, Functional, and Histological Considerations. J Craniofac Surg (2015) 0.81
Ridge Expansion by Flapless Split Crest and Immediate Implant Placement: Evolution of the Technique. J Craniofac Surg (2016) 0.81
Cdk9 phosphorylates Pirh2 protein and prevents degradation of p53 protein. Cell Cycle (2013) 0.81
A Patient With a Rare Single Mandibular Localization of Non-Hodgkin B-Cell Lymphoma: Early Differential Diagnosis With Dental Lesions. J Craniofac Surg (2015) 0.80
A new palatal distractor device for bodily movement of maxillary bones by rigid self-locking miniplates and screws system. J Craniofac Surg (2013) 0.80
Human glioblastoma ADF cells express tyrosinase, L-tyrosine hydroxylase and melanosomes and are sensitive to L-tyrosine and phenylthiourea. J Cell Physiol (2006) 0.80
Transient production of retroviral- and lentiviral-based vectors for the transduction of Mammalian cells. Methods Mol Biol (2004) 0.80
Transcriptional, biochemical and histochemical investigation on laccase expression during Tuber melanosporum Vittad. development. Phytochemistry (2012) 0.79
Fluorescence and electron microscopy methods for exploring antimicrobial peptides mode(s) of action. Methods Mol Biol (2010) 0.79
One-step transversal palatal distraction and maxillary repositioning: technical considerations, advantages, and long-term stability. J Craniofac Surg (2011) 0.79
Microbubble-assisted p53, RB, and p130 gene transfer in combination with radiation therapy in prostate cancer. Curr Gene Ther (2013) 0.79
Stem cells in cancer therapy: From their role in pathogenesis to their use as therapeutic agents. Drug News Perspect (2010) 0.79
Benzyl isothiocyanate inhibits HNSCC cell migration and invasion, and sensitizes HNSCC cells to cisplatin. Nutr Cancer (2014) 0.78
Maxillary constriction treated by a new palatal distractor device: surgical and occlusal evaluations of 10 patients. J Craniofac Surg (2010) 0.78
Osteodistraction With Dental Implant-Borne Devices for Bone Regeneration in Atrophied Premaxilla. J Craniofac Surg (2016) 0.77
Melphalan exposure induces an interleukin-6 deficit in bone marrow stromal cells and osteoblasts. Cytokine (2012) 0.77
pRB2/p130 target genes in non-small lung cancer cells identified by microarray analysis. Oncogene (2003) 0.77
New Technique for Mandibular Symphyseal Distraction by a Double-Level Anchorage and Fixation System: Advantages and Results. J Craniofac Surg (2016) 0.77
Tumor suppressor genes as cancer therapeutics. Drug News Perspect (2007) 0.77
Interview with the retinoblastoma family members: do they help each other? J Cell Physiol (2002) 0.77
Tyrosinase expression during black truffle development: from free living mycelium to ripe fruit body. Phytochemistry (2011) 0.77
Determination of functional viral titer by drug-resistance colony assay, expression of green fluorescent protein, and beta-galactoside staining. Methods Mol Biol (2004) 0.76
Interplay between the retinoblastoma related pRb2/p130 and E2F-4 and -5 in relation to JCV-TAg. J Cell Physiol (2007) 0.76
Cord blood CD133 cells define an OV6-positive population that can be differentiated in vitro into engraftable bipotent hepatic progenitors. Stem Cells Dev (2011) 0.76
Calcium ion cyclotron resonance (ICR) transfers information to living systems: effects on human epithelial cell differentiation. Electromagn Biol Med (2008) 0.76
Outcome of 47 consecutive sinus lift operations using aragonitic calcium carbonate associated with autologous platelet-rich plasma: clinical, histologic, and histomorphometrical evaluations. J Craniofac Surg (2009) 0.75
Antiangiogenic drugs currently used for colorectal cancer: what other pathways can we target to prolong responses? Drug News Perspect (2007) 0.75
The feasibility of gene therapy in the treatment of head and neck cancer. Head Neck Oncol (2009) 0.75
Efficacy of abiraterone acetate in post-docetaxel castration-resistant prostate cancer. Expert Rev Anticancer Ther (2010) 0.75
The limitless role of p53 in cell cycle machinery: good news or bad news? Cancer Biol Ther (2006) 0.75
Effects of stratospheric radiations on human glioblastoma cells. Ital J Biochem (2006) 0.75
Calcium ion cyclotron resonance (ICR), 7.0 Hz, 9.2 microT magnetic field exposure initiates differentiation of pituitary corticotrope-derived AtT20 D16V cells. Electromagn Biol Med (2010) 0.75
p53 and the malignant progression of Barrett's esophagus. J Cell Physiol (2006) 0.75
Osteodistraction With Dental Implant-Borne Devices for Bone Regeneration in Atrophied Premaxilla. J Craniofac Surg (2016) 0.75
Epigenome-derived drugs: recent advances and future perspectives. Drug News Perspect (2007) 0.75
Adenoviral gene therapy in high-grade malignant glioma. Drug News Perspect (2010) 0.75
Retroviral and lentiviral vector titration by the analysis of the activity of viral reverse transcriptase. Methods Mol Biol (2004) 0.75
Management of Zygomatic Fractures in Young Patients: Technical Modifications for Aesthetic and Functional Results. J Craniofac Surg (2016) 0.75
New Techniques in Relation to New Concepts of the Aesthetic of the Face: Technical Considerations and Aesthetic Evaluation. J Craniofac Surg (2016) 0.75